{
    "clinical_study": {
        "@rank": "97468", 
        "arm_group": [
            {
                "arm_group_label": "Acne patients", 
                "description": "This group consists of patients who have at least moderate to severe acne on their back"
            }, 
            {
                "arm_group_label": "Healthy Controls", 
                "description": "This group contains participants who do not have any active acne lesions on their back"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the response of acne patients and healthy control\n      patients to the P. acnes bacteria.  Half a tube of blood will be drawn from all participants\n      to determine whether or not they have antibodies to the P. acnes bacterium.  Anywhere from 1\n      to 4 skin biopsies of acne pimples or normal control skin will be taken from all subjects\n      for further analysis in the lab to determine whether the inflammation in these pimples can\n      be reduced using anti-P.acnes antibodies."
        }, 
        "brief_title": "Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acne", 
        "condition_browse": {
            "mesh_term": "Acne Vulgaris"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Fits into one of the following diagnostic groups:\n\n               1. Healthy subject with no active skin disease or history of skin disease\n\n               2. Diagnosis of moderate-to-severe truncal acne diagnosed clinically and confirmed\n                  using the modified Leeds criteria with no reported use of topical acne\n                  treatments within the past 2 weeks prior to enrollment in the study, and no\n                  reported use of oral acne treatments during the past 4 weeks prior to enrollment\n                  in the study\n\n               3. Diagnosis of moderate-to-severe truncal acne diagnosed clinically and confirmed\n                  using the modified Leeds criteria who has used any topical acne treatments in\n                  the 2 weeks prior to enrolling in the study, or who has used any oral acne\n                  treatments during the 4 weeks prior to enrolling in the study 2.      Age 18-60\n                  years 3. Male or female of any race and ethnicity 4. Subject agrees to comply\n                  with study requirements\n\n        Exclusion Criteria:\n\n          1. Subjects with severe medical condition(s) that in the view of the investigator\n             prohibits participation in the study\n\n          2. Subject has Netherton's syndrome or other genodermatoses that result in a defective\n             epidermal barrier\n\n          3. Pregnant or nursing females\n\n          4. Immunocompromised subjects (e.g., lymphoma, HIV/AIDS, Wiskott-Aldrich Syndrome), or\n             with a history of active or malignant disease (excluding non-melanoma skin cancer) as\n             determined by the participant's medical history.\n\n          5. Subjects with a history of psychiatric disease or history of alcohol or drug abuse\n             that would interfere with the ability to comply with the study protocol\n\n          6. Subjects with significant concurrent medical condition(s) at screening that in the\n             view of the investigator prohibits participation in the study (e.g., severe\n             concurrent allergic disease, condition associated with malignancy, and condition\n             associated with immunosuppression)\n\n          7. Active viral or fungal skin infections at the target areas\n\n          8. Are currently receiving lithium now or within the last 4 weeks.\n\n          9. Ongoing participation in an investigational drug trial\n\n         10. Use of any systemic immunosuppressive therapy less than four weeks prior to\n             screening.\n\n         11. Subjects with diabetes\n\n         12. Injured, broken skin that, per the investigator, may lead to poor wound healing\n\n         13. Subjects with allergies to anesthetic medications"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "community sample"
            }
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01929057", 
            "org_study_id": "121230"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Acne patients", 
                    "Healthy Controls"
                ], 
                "description": "4-millimeter punch biopsies will be performed on all subjects (acne patients and healthy controls)", 
                "intervention_name": "Skin biopsy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Acne patients", 
                    "Healthy Controls"
                ], 
                "description": "Approximately half a tube of blood will be drawn from all participants in the study", 
                "intervention_name": "Blood draw", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "contact": {
                "email": "ucsddermstudies@gmail.com", 
                "last_name": "Aimee Two, MD", 
                "phone": "858-657-8390"
            }, 
            "facility": {
                "address": {
                    "city": "San Diego", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "92122"
                }, 
                "name": "UCSD Division of Dermatology"
            }, 
            "investigator": {
                "last_name": "Tissa Hata, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris", 
        "overall_contact": {
            "email": "ucsddermstudies@gmail.com", 
            "last_name": "Aimee Two, MD", 
            "phone": "858-657-8390"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Inflammatory markers", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01929057"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of California, San Diego", 
            "investigator_full_name": "Tissa Hata, MD", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "P. acnes antibody levels", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "source": "University of California, San Diego", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of California, San Diego", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}